Information about the medicines and adherence to high activity antiretroviral treatment in patients with HIV/Aids in a hospital of Lima, Peru

Juana Pacífico, César Gutiérrez

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

© 2015, Instituto Nacional de Salud. All rights reserved. Objectives: Determine the association between the information received on high activity antiretroviral treatment (HAART) and the adherence to this treatment in patients with HIV / AIDS of a hospital of Lima, Peru. Materials and methods: Cross-sectional analytical study. Through interviews were applied the questionnaire SIMS (Satisfaction with Information about Medicines Scale) to measure satisfaction with information received about medications and SMAQ (Simplified Medication Adherence Questionnaire) to determine adherence to HAART. By reviewing medical records sociodemographic and clinical data were collected. Results: 364 patients were interviewed. Satisfaction with the information received about drugs was not associated with adherence to HAART (p = 0.611). Factors associated with the satisfaction with information were: female (ORa = 0.52; 95% CI 0.30 to 0.90); level of higher education (ORa = 0.45; 95% CI 0.27 to 0.75) and age (ORa = 1.05; 95% CI 1.02 to 1.08). There were more satisfaction with the information received on the action and drug use compared with information about potential adverse events (48.9% vs. 43.1%; p = 0.0291). Conclusions: Satisfaction with information received about drugs was not associated with adherence to HAART. This satisfaction increases with age and is lower in females and in the degree of higher education. There are desires for further information on the potential adverse reactions to HAART.
Original languageAmerican English
Pages (from-to)66-72
Number of pages7
JournalRevista Peruana de Medicina Experimental y Salud Publica
StatePublished - 1 Jan 2015

Fingerprint

Dive into the research topics of 'Information about the medicines and adherence to high activity antiretroviral treatment in patients with HIV/Aids in a hospital of Lima, Peru'. Together they form a unique fingerprint.

Cite this